| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 726195 | 2-phenyl 3-[(6-ethyl, 4-amino, 5-(4-chlorophenyl) pyrimidin-2-yl)] quinazolin-4-one | 0.0130195548838507 | 0.51868514 |
| NSC 732568 | 6,8-Dibromo-2-phenyl-3-[5?-amino6?(2??,3??-dichlorophenyl)1, 2,4-triazin-3-yl]quinazolin-4(3H)-one (SPC-IIIBr) | 0.0130195548838507 | 0.39926132 |
| NSC 736122 | 1-(Benzothien-3'-yl)-3,4-dihydronaphthalene-2-acrylic acid ethyl ester | 0.0130195548838507 | 0.1227307 |
| NSC 174121 | Methotrexate Derivative | 0.0131142867047949 | 0.67027004 |
| NSC 181500 | Null | 0.0131142867047949 | 0.32693668 |
| NSC 191924 | Null | 0.0131142867047949 | 0.37799229 |
| NSC 335787 | 1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(6-methyl-2-pyridinyl)ethylidene]hydrazide | 0.0131142867047949 | 0.3141382 |
| NSC 376266 | 1-Piperazinethiocarboxylic acid, 4-(2-propynyl)- 2-[1-(2-pyridinyl)ethylidene]hydrazide | 0.0131142867047949 | 0.43237401 |
| NSC 647638 | 1,2-Dioxin-3-acetic acid, 3,6-dihydro-6-methoxy-6-(14,16- octadecadienyl)-, methyl ester, [3.alpha.,6.alpha.,6(14E,16E)]-(+)- (9CI) | 0.0131142867047949 | 0.070688135 |
| NSC 658145 | 2-(2-(Dimethylamino)ethylamino)naphthazarin | 0.0131142867047949 | 0.48764456 |